Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -111.42% is 175% below its 5-year average of -40.52%, near the low end of its 5-year range (-111.42%–-12.61%).
As of the fiscal period ended Tuesday, June 30, 2026. 29.83% below its 12-month average of -85.82%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -111.42%.
RETURN ON INVESTED CAPITAL (ROIC)
-111.42%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-85.82%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-56.97%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-40.52%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-29.83%
CURRENT VS 3Y AVG
-95.58%
CURRENT VS 5Y AVG
-174.94%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.66%
median of 837 covered companies
CURRENT VS SECTOR MEDIAN
-212.45%
vs the sector median at left
PMV Pharmaceuticals, Inc.
Market Cap
$85.86M
Return on Invested Capital (ROIC)
-111.42%
TTM Avg
-85.82%
3Y Avg
-56.97%
5Y Avg
-40.52%
Market Cap
$87.27M
Return on Invested Capital (ROIC)
-216.05%
TTM Avg
-121.78%
3Y Avg
-79.31%
5Y Avg
-71.06%
Market Cap
$84.13M
Return on Invested Capital (ROIC)
-109.43%
TTM Avg
-208.02%
3Y Avg
-178.83%
5Y Avg
-203.50%
Market Cap
$87.85M
Return on Invested Capital (ROIC)
-100.35%
TTM Avg
-639.99%
3Y Avg
-358.78%
5Y Avg
-266.51%
Market Cap
$87.96M
Return on Invested Capital (ROIC)
12.79%
TTM Avg
17.38%
3Y Avg
-11.40%
5Y Avg
-8.36%
Market Cap
$82.59M
Return on Invested Capital (ROIC)
-87.79%
TTM Avg
-271.72%
3Y Avg
-628154.34%
5Y Avg
-503132.91%
Market Cap
$82.53M
Return on Invested Capital (ROIC)
-120.93%
TTM Avg
-913.64%
3Y Avg
-646.22%
5Y Avg
-579.89%
Market Cap
$82.47M
Return on Invested Capital (ROIC)
-159.30%
TTM Avg
-82.85%
3Y Avg
-66.58%
5Y Avg
-50.22%
Market Cap
$89.44M
Return on Invested Capital (ROIC)
-217.73%
TTM Avg
-143.58%
3Y Avg
-163.00%
5Y Avg
-133.51%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| PMV Pharmaceuticals, Inc. (PMVP) | $85.86M | -111.42% | -85.82% | -56.97% | -40.52% |
| Neumora Therapeutics, Inc. Common Stock (NMRA)vs › | $87.27M | -216.05% | -121.78% | -79.31% | -71.06% |
| Cognition Therapeutics, Inc. (CGTX)vs › | $84.13M | -109.43% | -208.02% | -178.83% | -203.50% |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $87.85M | -100.35% | -639.99% | -358.78% | -266.51% |
| CareCloud, Inc. (CCLD)vs › | $87.96M | 12.79% | 17.38% | -11.40% | -8.36% |
| ProMIS Neurosciences, Inc. (PMN)vs › | $82.59M | -87.79% | -271.72% | -628154.34% | -503132.91% |
| Telomir Pharmaceuticals, Inc. Common Stock (TELO)vs › | $82.53M | -120.93% | -913.64% | -646.22% | -579.89% |
| Cardiff Oncology, Inc. (CRDF)vs › | $82.47M | -159.30% | -82.85% | -66.58% | -50.22% |
| electroCore, Inc. (ECOR)vs › | $89.44M | -217.73% | -143.58% | -163.00% | -133.51% |
| LENSAR Inc (LNSR)vs › | $82.29M | -16.28% | -50.22% | -41.74% | -37.86% |
ROIC
-111.4%
ROE
-105.2%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -111.42% |
| 2026-03-31 | -95.11% |
| 2025-12-31 | -81.99% |
| 2025-09-30 | -75.80% |
| 2025-06-30 | -64.78% |
| 2025-03-31 | -55.20% |
| 2024-12-31 | -48.20% |
| 2024-09-30 | -37.72% |
| 2024-06-30 | -34.01% |
| 2024-03-31 | -34.19% |
| 2023-12-31 | -33.65% |
| 2023-09-30 | -32.92% |
| 2023-06-30 | -35.59% |
| 2023-03-31 | -32.83% |
| 2022-12-31 | -29.69% |
| 2022-09-30 | -27.20% |
| 2022-06-30 | -24.23% |
| 2022-03-31 | -21.51% |
| 2021-12-31 | -18.25% |
| 2021-09-30 | -14.99% |
| 2021-06-30 | -12.61% |
| 2021-03-31 | -11.18% |
| 2020-12-31 | -9.73% |
| 2020-09-30 | -8.62% |
| 2020-06-30 | -35.15% |
| 2019-12-31 | -27.04% |
